Drug details

Rolvedon (eflapegrastim-xnst for injection)

type of Hematopoietic Growth Factors

Rolvedon (eflapegrastim-xnst) is a leukocyte growth factor indicated to decrease the incidence of infection, as manifested by febrile neutropenia, in adult patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with clinically significant incidence of febrile neutropenia.

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• shortness of breath,
• dizziness,
• cough,
• abdominal pain,
• decreased appetite,
• pain or discomfort,
• swelling in your arms and legs,
• low platelet levels,
• pain in your arms and legs, and
• injection site reaction

The following drugs are related to Rolvedon, either as a replacement or used together:

• Ambisome (amphotericin b)
• Amikin (amikacin)
• Cancidas (caspofungin acetate for injection)
• Fortaz (ceftazidime)
• Cipro XR (ciprofloxacin extended-release)
• Sporanox (itraconazole capsules)
• Sporanox Injection (itraconazole injection)
• Sporanox Oral Solution (itraconazole oral solution)
• Zosyn (piperacillin and tazobactam injection)
• Zosyn Injection (piperacillin and tazobactam pharmacy bulk vial)
• Tobi (tobramycin)
• TOBI Podhaler (tobramycin inhalation powder)